E-mail  |   Log in
News Center
Ningbo Aucheer Biotechnology Co., Ltd
audir
audir
audir
Conference Review|The 14th National Conference on Obstetrics and Gynecology of Chinese Medical Association

Conference Review|The 14th National Conference on Obstetrics and Gynecology of Chinese Medical Association

(Summary description)

Conference Review|The 14th National Conference on Obstetrics and Gynecology of Chinese Medical Association

(Summary description)

 
 

Click "Aocheng Bio" above to follow and get the latest information!

 

  Content of meeting

 

November 1, 2019.The 14th National Obstetrics and Gynecology Academic Conference of the Chinese Medical Association Obstetrics and Gynecology Branch hosted by the Chinese Medical Association and the Obstetrics and Gynecology Branch of the Chinese Medical Association was held in Zhuhai.Professor Shen Keng from the Obstetrics and Gynecology Branch of the Chinese Medical Association delivered an opening speech. Academician Lang Jinghe of the Chinese Academy of Engineering, Professor David Cranston, Director of the FUS Center of Churchill Hospital, Oxford University, and other experts from home and abroad gathered together.

At this meeting, Academician Lang Jinghe of the Chinese Academy of Engineering said that we have always advocated and adhered to standardization, individualization, minimally invasiveness, and humanization in the diagnosis and treatment of obstetrics and gynecology diseases. Humanization means respecting people, respecting patients, and protecting organs. To protect the organization, the protective function is the greatest respect for the patient. When choosing our treatment methods and methods, we must insist on maximizing the benefits of treatment and minimizing the harm of treatment.

 

 

  Pregnancy-induced hypertension session 

 

On November 2nd, the special meeting of the Pregnancy-induced Hypertension Group was held. Professor Zhang Weiyuan, the leader of the Pregnancy-induced Hypertension Group, gave an opening speech. Professor Zhang reviewed the major events and important achievements since the establishment of the school group.

 

 

Professor Lin Jianhua shared a multi-center project report based on the investigation and analysis of the incidence of hypertension in pregnancy in my country. According to the statistics obtained, the incidence of hypertension in pregnancy is 4.86%, and the incidence of preeclampsia is 2.47%.

 

 

 

Professor Sun Lizhou shared research topics related to the relationship between preeclampsia and intestinal flora, and pointed out that there are differences in the composition of intestinal flora between pregnant women with preeclampsia and normal pregnant women.

 

 

Next, Professor Niu Jianmin focused on the prediction and prevention of preeclampsia, and pointed out that the traditional prediction method using maternal factors has a low detection rate and is not suitable for early screening. The screening model of the British Fetal Foundation combines maternal factors. , Mean arterial pressure, PlGF, uterine artery pulsation index, can increase the detection rate to 93.4%, which is a more suitable early screening method.

 

 

Later, Professor Yan Jianying and Professor Chen Xu shared the timing of pregnancy termination based on preeclampsia and related management during and after delivery.

 

Professor Yang Zi has paid attention to the multi-factor, multi-mechanism and multi-pathway influences that must be paid attention to in the research of preeclampsia from different angles. We must analyze and consider from multiple perspectives in the process of research and attention.

 

 

Finally, Professor Zhang Weiyuan, the leader of the study group, summarized the meeting of the study group. In addition to the achievements, he also summarized the current problems of the study group and the work that needs to be completed in the future.

 

 

  Aucheer iRaTe PlGF detection reagent 

 

At the same time, Ningbo Aocheng was invited and sponsored this academic annual meeting. During the meeting, Aocheng brought the Aucheer iRate PlGF test reagent independently developed to help the development of my country's obstetrics and gynecology and contribute to the diagnosis and treatment of hypertension in pregnancy in my country. strength.

 

The Aucheer iRate PlGF test reagent can help clinicians more reasonably carry out risk stratification and clinical assessment of high-risk factors and pregnant women with suspected preeclampsia, strengthen the management of preeclampsia, reduce or delay the occurrence and development of preeclampsia, and ensure the safety of mothers and fetuses.

 

 

Features

 

 

●Methodology:Time-resolved immunofluorescence

 

Linear range:12-3000pg/mL

 

 Specimen type:Serum, plasma or whole blood

 

 Accuracy:CV≤15%

 

 Detection time:12min

 

 Can be connected to the LIS system in the hospital

相关资讯

Aucheer
Contact:86-574-87732259
Technical Support:400-008-6588
Aucheer
Business Mailbox:info1@aucheer.net
HR Mailbox :hr@aucheer.net
Aucheer
Address: North Building B, No. 885, Chunhua Rd., Wangchun Industrial Zone, Haishu District, Ningbo, Zhejiang Province, China 
Aucheer
Aucheer Bio
Aucheer
Aucheer Medical

© 2021 Ningbo Aucheer Biotechnology Co., Ltd | 浙ICP备17032133号-2Powered by www.300.cn